06.07.2015
- ViiV Healthcare, the HIV unit of GlaxoSmithKline, has signed an agreement with Shanghai-based Desano Pharmaceuticals under which the Chinese group will produce the active...
21.01.2015
- GlaxoSmithKline could consider more partial public share offerings for component units as it evolves in the coming years, potentially pointing to a break-up of the group if this...
27.02.2013
- GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor...
29.10.2012
- GlaxoSmithKline has raised its bet on a promising drug for HIV/AIDS by redrawing a deal with Japan's Shionogi, giving it a much bigger economic interest in the new product...
03.11.2011
- Viiv Healthcare, a GlaxoSmithKline and Pfizer joint venture, will start manufacturing HIV medicines in Russia in partnership with local drugmaker Binnopharm. Agreeing a local...
